About Ergomed
Ergomed is a company based in Guildford (United Kingdom) founded in 1997 was acquired by Permira in September 2023. Ergomed has completed 9 acquisitions, including ADAMAS Consulting, Ergomed and GASD. Ergomed offers products and services including Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting. Ergomed operates in a competitive market with competitors including hVIVO, Chiltern International, ClinTec, Avillion and Celadon Pharmaceuticals, among others.
- Headquarter Guildford, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ergomed Plc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$5.53 M (USD), Post-IPO
Feb 01, 2018
-
Investors
Permira
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
ADAMAS Consulting
& 8 more
-
Acquired by
Permira
(Sep 04, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ergomed
Ergomed offers a comprehensive portfolio of products and services, including Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting.
Full-service CRO for oncology and rare diseases trials
End-to-end PV services from clinical development to post-marketing
Full range of GxP audits for drug development and surveillance
People of Ergomed
Unlock access to complete
Funding Insights of Ergomed
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $5.5M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2018 | Amount | Post-IPO - Ergomed | Valuation |
investors |
|
| Jun, 2005 | Amount | Series A - Ergomed | Valuation |
investors |
Investors in Ergomed
Ergomed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and Catapult Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment solutions are provided by Catapult Ventures for growth.
|
Founded Year | Domain | Location | |
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ergomed
Ergomed has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include ADAMAS Consulting, Ergomed and GASD.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmacovigilance and regulatory services are provided to pharmaceutical firms.
|
2010 | ||||
|
Pharmacovigilance and regulatory services for drugs and devices are provided.
|
2008 | ||||
|
Functional CRO offering pharmacovigilance services
|
2008 |
Financial Statements - Ergomed
Ergomed Comparisons
Competitors of Ergomed
Ergomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as hVIVO, Chiltern International, ClinTec, Avillion and Celadon Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of cell based assays, field trial, and molecular services for biopharma sector
|
|
| domain | founded_year | HQ Location |
Full service CRO with expertise in oncology related development services
|
|
| domain | founded_year | HQ Location |
Clinical research services are provided globally to pharmaceutical industries.
|
|
| domain | founded_year | HQ Location |
Clinical co-development services and financing for late-stage therapeutics are provided.
|
|
| domain | founded_year | HQ Location |
Provider of cannabis trial services
|
Frequently Asked Questions about Ergomed
Ergomed was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Ergomed is headquartered in Guildford, United Kingdom.
Ergomed is a CRO operating in 50 countries with two complementary businesses. As part of its co-development business, the company offers drug development services in exchange for revenues and out-licensing milestones w.r.t the sale and development of the product. The company has signed 5 such deals so far with different pharma companies. The company has acquired Haemostatix, along with a pipeline of proprietary development products for haemostasis in surgical settings.
Ergomed's top competitors include hVIVO, Chiltern International and Avillion.
Ergomed offers Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting.
Ergomed has made 9 acquisitions, including ADAMAS Consulting, Ergomed, and GASD.
Ergomed has 2 investors. Key investors include Permira, and Catapult Ventures.